# Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With Dysmenorrhea

> **NCT05900336** · PHASE4 · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 70 (actual)

## Conditions studied

- Dysmenorrhea
- Menstrual Pain
- Non-steroidal Anti-inflammatory Drug

## Interventions

- **DRUG:** Sodium Naproxen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05900336
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-25
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05900336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05900336, "Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With Dysmenorrhea". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05900336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*